An October 14 headline asks whether pipeline growth can restore confidence after Alnylam cut its guidance. The supplied information doesn’t explain the size or reason for the cut, or identify any pipeline milestones. Alnylam shares rose for the day but remain sharply lower year to date.
Investor takeaway: The headline raises a question about pipeline growth and a guidance cut, but there isn’t enough information here to assess either.
Alnylam shares closed at US$234.91
Advertisement
Alnylam Pharmaceuticals Inc
ALNY.US
ALNY.US
Alnylam Pharmaceuticals Inc
WealthAwesomeMarket cap
$30.04B
P/E
37.7x
52W high
$495.55
52W low
$197.81
1W change
+4.23%
Beta
0.27
Analyst Price Targets
Based on 29 analysts covering ALNY · as of Oct 16, 2026
Wall Street analysts forecast ALNY stock price to rise 58.0% over the next 12 months.
Consensus
Buy4.31 / 5.00
Avg. Target
C$369.66
+58.0% Upside
Previously C$370.55 on Oct 12, 2026
Current Price
C$234.03
Last close
Analyst Breakdown (29 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ALNY's historical volatility
30-Day Vol
41.5%
Annualized
90-Day Vol
70.9%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$195.76
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$220.51 | C$191.07 – C$254.48 |
| 60 trading days | C$207.76 | C$169.65 – C$254.44 |
| 90 trading days | C$195.76 | C$152.73 – C$250.91 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
The close was 1.3% below the 50-day moving average and 20.6% below the 200-day average. Reported volume was 203,994 shares, or 0.98 times the supplied average-volume figure.
Bull case
Alnylam shares gained 4.26% in one day. The headline also points to pipeline growth as a possible source of renewed confidence.
Bear case
The headline mentions a guidance cut but doesn’t say how large it was or what prompted it. The supplied information also names no pipeline milestones. Shares are down 41.52% year to date.
What happened: headline raises a pipeline question
An October 14 end-of-day headline compares Alnylam with IONS and ARWR and asks whether pipeline growth can restore confidence after a guidance cut. It doesn’t say which guidance changed, by how much, or why. Nor does it name pipeline programs, report trial results, or give development timelines. So the headline poses a question rather than providing details about the cut or pipeline progress.
A separate October 15 company-news item says Alnylam planned a webcast about its third-quarter 2026 financial results. The supplied information doesn’t include the results or details of the call. See the ALNY.US stock page.
Advertisement
What the numbers show: a daily gain amid a year-to-date decline
Alnylam closed at US$234.91, up 4.26% for the day and 4.23% for the week. Shares fell 1.78% over the month and 41.52% year to date.
The close was US$3.08 below the 50-day moving average of US$237.99 and US$61.04 below the 200-day average of US$295.95. Reported volume was 203,994 shares. The supplied volume figure was 0.98 times the 20-day average of 1,284,682 shares. The 52-week range was US$197.81 to US$495.55.
These figures describe the stock’s performance, but they don’t explain the daily move or show how investors viewed the guidance headline.
What to watch next: details behind the cut and pipeline
To assess the headline’s central question, investors need details about the size and reason for the guidance cut, as well as any pipeline milestones that could affect confidence. The October 15 item points to a webcast about third-quarter 2026 results, but no financial details or webcast outcome are provided here. Alnylam company information is also available on the ALNY.US stock page.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
